Abstract

Background: The role of regulatory T cells (Tregs) in the development of SSc has started being studied during the last decade with new aspects being disclosed continuously. Although there is a general agreement in the medical literature regarding the decreased functional capacity of circulating Tregs in SSc, the alteration of absolute number of Treg and Th17 cells as well as their associations with clinical characteristics of SSc are still unclear. Objectives: The present study was to investigate the relationship between multiple system impairments, disease activity and the absolute number of CD4+CD25+FOXP3+ regulatory T cells (Treg cells) and interleukin 17 producing T help cells (Th17) in peripheral blood of patients with systemic sclerosis (SSc). Methods: Clinical indicators were collected from total 54 patients with SSc[8 with localized SSc (lcSSc) and 46 with diffuse SSc (dcSSc)] who were divided into two groups, mainly with skin lesions (n=11) and with multiple system and organ besides skin lesions (n=43). Then according to the SSc EUSTAR index, we divided 54 SSc patients into the inactive (EUSTAR Results: We found that SSc, especially dcSSc patients, had significantly fewer peripheral CD4Treg cells (both absolute number and proportion, p Conclusion: The reduced absolute number of peripheral Treg cells in SSc patients was contributed to the imbalance of Th17/Treg cells and involved in the pathogenesis of SSc, and may promote multiple system impairments and disease activity.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call